Augur Signals: News Feed

Report Archive – January 2024

Augur Signals: News Feed
Biotechnology , Healthcare , Alert

Insider Buying Alert: A Potential Catalyst for Talaris Therapeutics, Inc.

  • Acquired: Non-Derivative
An insider trading alert was triggered by Mark McDade, director and ten percent owner of Talaris Therapeutics, Inc. (TRML), after purchasing 100,000 shares valued at $3.7 million. This increased his total shares to 448,431. The biotech sector's volatility, combined with McDade's historical ROI of 52.36%, suggests confidence in the company's prospects. Despite a P/E Ratio of -6.22, the P/B Ratio of 1.84 indicates fair valuation. The stock price was $35.17, with potential short-term gains to $37.00 and $38.50.
Biotechnology , Healthcare , Alert

Insider Trading Alert: Shenouda Maged Buys Relmada Therapeutics, Inc. Stock

  • Acquired: Non-Derivative
Insider Trading Alert: Shenouda Maged Buys Relmada Therapeutics, Inc. Stock
On January 30, 2024, Shenouda Maged of Relmada Therapeutics, Inc. purchased 15,000 shares worth approximately $59,700, raising his total to 28,028 shares. Having completed 62 transactions since 2015 with positive returns, Maged's strategic acquisitions reflect confidence in Relmada, despite its mixed valuation signals. The stock, priced at $3.975, is projected to rise, potentially reaching $4.30 within four weeks, supported by historical performance and market momentum.
REIT - Hotel & Motel , Real Estate , Alert

Insider Trading Alert: Chase Jr Buys InnSuites Hospitality REIT Shares

  • Acquired: Non-Derivative
Insider Trading Alert: Chase Jr Buys InnSuites Hospitality REIT Shares
On January 24, 2024, Chase Jr, a director of InnSuites Hospitality Trust, purchased 500 shares of InnSuites Hospitality REIT for approximately $640, increasing his holdings to 73,459 shares. Historically, Chase Jr has shown strong performance with an annualized ROI of 1197.45%. The REIT sector, particularly hotels, shows mixed valuation signals. The Price-to-Book ratio of 3.46 suggests overvaluation, while the Price-to-Sales ratio of 2.48 indicates potential undervaluation. A short-term bullish sentiment is anticipated, with a predicted price range of $1.32 to $1.40.
Entertainment , Communication Services , Alert

Insider Trading Alert: Allied Gaming & Entertainment Inc. Sees Significant Insider Buying

  • Acquired: Non-Derivative
Insider Trading Alert: Allied Gaming & Entertainment Inc. Sees Significant Insider Buying
On January 22, 2024, Knighted Pastures LLC, a significant stakeholder in Allied Gaming & Entertainment Inc., purchased 21,300 shares of Common Stock. This insider, a ten percent owner, has shown strategic purchasing patterns with past ROI of 29.18%. The stock's P/B ratio is 0.42, indicating undervaluation, while the P/S ratio is 5.05, suggesting overvaluation. Current technical indicators show mixed signals with a target price of $1.22 to $1.25 in the short term. Investors should watch the high P/S ratio and market trends.
Biotechnology , Healthcare , Alert

Insider Trading Alert: Strategic Moves in Biotechnology

  • Acquired: Non-Derivative
Insider Trading Alert: Strategic Moves in Biotechnology
The recent insider trading activity at Assembly Biosciences, Inc. highlighted a significant transaction by Alexander Schornstein on January 17, 2024. He purchased 24,993 shares, bringing his total holdings to 7,864,286 shares. Despite fluctuating sentiments in the biotechnology sector, past insider transactions have shown a positive ROI of 19.72%. The stock, priced at $9.93 as of January 19, 2024, is predicted to rise to $10.20 - $10.50 in the short term, based on valuation metrics and technical indicators like the RSI and MACD.
Medical Devices , Healthcare , Alert

Insider Trading Alert: What Does the Recent Purchase Mean for electroCore, Inc.?

  • Acquired: Non-Derivative
Insider Trading Alert: What Does the Recent Purchase Mean for electroCore, Inc.?
On January 12, 2024, Brian M. Posner of electroCore, Inc. purchased 16,000 shares at $6.17 each, totaling approximately $98,720. This increased his holdings to 22,437 shares. The purchase occurred amid a decrease in market volume to 10,800 shares. Brian M. Posner has a history of 49 insider transactions since July 16, 2010, with a 10.15% annualized ROI. electroCore, Inc. shows a negative P/E ratio of -24.75 but a high P/B ratio of 10.98. Price predictions suggest a short-term increase to $7.10, a 5.8% rise, considering insider performance and market trends.
Biotechnology , Healthcare , Alert

Insider Trading Alert: Significant Purchase by Lim Kok Thay at Celularity Inc.

  • Acquired: Non-Derivative
Insider Trading Alert: Significant Purchase by Lim Kok Thay at Celularity Inc.
On , Lim Kok Thay, a ten percent owner of Celularity Inc. (CELU), purchased 2,145,044.9446 shares of Class A Common Stock, increasing his holdings to 51,473,762 shares. Known for an impressive 140,326.32% ROI in past transactions, his recent acquisition suggests confidence in the company's future. The transaction occurred with a closing price of $2.17, below the 16-week average of $2.22. Technical indicators show an oversold condition, with a short-term target price of $2.10 to $2.25.
Software—Application , Technology , Alert

Insider Trading Alert: Strategic Moves by Peter A Jr Bordes at Collective Audience, Inc.

  • Acquired: Non-Derivative
Insider Trading Alert: Strategic Moves by Peter A Jr Bordes at Collective Audience, Inc.
On January 16, 2024, Peter A Jr Bordes of Collective Audience, Inc. purchased 20,000 shares, enhancing his total to 1,211,429 shares. Valued at approximately $18,800, the stock closed at $0.94. Collective Audience, Inc. operates in the Technology sector, with a P/B ratio of 1.67, indicating undervaluation. The NASDAQ Composite Index shows moderate momentum, potentially benefiting technology stocks. Bordes' confidence and the stock's undervaluation suggest potential for price appreciation, with a target of $1.10 in the short term.
Software—Application , Technology , Alert

Insider Trading Alert: What Does the Recent Buy Mean for Collective Audience, Inc.?

  • Acquired: Non-Derivative
Insider Trading Alert: What Does the Recent Buy Mean for Collective Audience, Inc.?
On January 16, 2024, Peter A. Bordes Jr. of Collective Audience, Inc. purchased 20,000 shares at approximately $18,800, raising his holdings to 1,211,429 shares. His strategic approach has historically yielded a 62.88% annualized ROI. The stock is currently undervalued with a P/B ratio of 1.67, below the industry median. Despite bearish technical indicators, the insider's confidence and undervaluation suggest potential future gains.
Biotechnology , Healthcare , Alert

Insider Trading Alert: A Significant Buy in Dyne Therapeutics, Inc. by Kersten Dirk

  • Acquired: Non-Derivative
Insider Trading Alert: A Significant Buy in Dyne Therapeutics, Inc. by Kersten Dirk
On January 9, 2024, Kersten Dirk, a director and ten percent owner of Dyne Therapeutics, Inc., purchased 1,714,285 shares of Common Stock for approximately $32.2 million, enhancing his total holdings to 6,416,793 shares. This acquisition reflects confidence in the company's future amid a volatile biotechnology sector. Kersten Dirk has a history of successful insider transactions, with a ROI of 55.46% on transactions older than 16 weeks. The stock's current price is $16.6188, with a predicted short-term target range of $17.50 to $18.50.

Back

Pages total: 2

Calendar